Value of 3T Susceptibility-Weighted Imaging in the Diagnosis of Multiple Sclerosis
Margareta A. Clarke(University of Nottingham), Àlex Rovira(Centre National de la Recherche Scientifique), Cristina Auger(MACOM (United States)), Lucas M. Pessini(Universitat Autònoma de Barcelona), Sarah Cappelle(KU Leuven), Jaume Sastre‐Garriga(Universitat Autònoma de Barcelona), Deborah Pareto(Universitat Autònoma de Barcelona), Xavier Montalbán(Universitat de Vic - Universitat Central de Catalunya), Mar Tintoré(Vall d'Hebron Hospital Universitari), Manel Alberich(MACOM (United States)), Francesco Crescenzo(University of Verona), Georgina Arrambide(Universitat Autònoma de Barcelona), Nikos Evangelou(Brigham and Women's Hospital)
Cited by 132
Related Papers
Diagnostic criteria for multiple sclerosis: 2010 Revisions to the McDonald criteria
|Annals of Neurology|2011|9.8k
Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria
|The Lancet Neurology|2017|8k
Defining the clinical course of multiple sclerosis
|Neurology|2014|3.1k
Oral Fingolimod or Intramuscular Interferon for Relapsing Multiple Sclerosis
|New England Journal of Medicine|2010|2.2k
Ocrelizumab versus Interferon Beta-1a in Relapsing Multiple Sclerosis
|New England Journal of Medicine|2016|2k